Notice of Award of a Single-Source Grant To Fund Task Force for Global Health, Inc., 46257-46258 [2021-17678]
Download as PDF
<![CDATA[
Federal Register / Vol. 86, No. 157 / Wednesday, August 18, 2021 / Notices
jbell on DSKJLSW7X2PROD with NOTICES
review and, as appropriate, revise the
list of vaccines for administration to
vaccine-eligible children through the
Vaccines for Children (VFC) program,
along with schedules regarding dosing
interval, dosage, and contraindications
to administration of vaccines. Further,
under provisions of the Affordable Care
Act, section 2713 of the Public Health
Service Act, immunization
recommendations of the ACIP that have
been approved by the Director of the
Centers for Disease Control and
Prevention and appear on CDC
immunization schedules must be
covered by applicable health plans.
Matters To Be Considered: The agenda
will include discussions on additional
doses of COVID–19 vaccine, including
booster doses. Agenda items are subject
to change as priorities dictate. For more
information on the meeting agenda visit
https://www.cdc.gov/vaccines/acip/
meetings/meetings-info.html.
Meeting Information: The meeting
will be webcast live via the World Wide
Web; for more information on ACIP
please visit the ACIP website: https://
www.cdc.gov/vaccines/acip/.
Public Participation
Interested persons or organizations
are invited to participate by submitting
written views, recommendations, and
data. Please note that comments
received, including attachments and
other supporting materials, are part of
the public record and are subject to
public disclosure. Comments will be
posted on https://www.regulations.gov.
Therefore, do not include any
information in your comment or
supporting materials that you consider
confidential or inappropriate for public
disclosure. If you include your name,
contact information, or other
information that identifies you in the
body of your comments, that
information will be on public display.
CDC will review all submissions and
may choose to redact, or withhold,
submissions containing private or
proprietary information such as Social
Security numbers, medical information,
inappropriate language, or duplicate/
near duplicate examples of a mass-mail
campaign. CDC will carefully consider
all comments submitted into the docket.
Written Public Comment: Written
comments must be received on or before
August 24, 2021.
Oral Public Comment: This meeting
will include time for members of the
public to make an oral comment. Oral
public comment will occur before any
scheduled votes including all votes
relevant to the ACIP’s Affordable Care
Act and Vaccines for Children Program
roles. Priority will be given to
VerDate Sep<11>2014
17:34 Aug 17, 2021
Jkt 253001
individuals who submit a request to
make an oral public comment before the
meeting according to the procedures
below.
Procedure for Oral Public Comment:
All persons interested in making an oral
public comment at the August 24, 2021,
ACIP meeting must submit a request at
https://www.cdc.gov/vaccines/acip/
meetings/ no later than 11:59 p.m., EDT,
August 22, 2021, according to the
instructions provided.
If the number of persons requesting to
speak is greater than can be reasonably
accommodated during the scheduled
time, CDC will conduct a lottery to
determine the speakers for the
scheduled public comment session.
CDC staff will notify individuals
regarding their request to speak by email
by 12:00 p.m., EDT, August 23, 2021. To
accommodate the significant interest in
participation in the oral public
comment session of ACIP meetings,
each speaker will be limited to 3
minutes, and each speaker may only
speak once per meeting.
The Director, Strategic Business
Initiatives Unit, Office of the Chief
Operating Officer, Centers for Disease
Control and Prevention, has been
delegated the authority to sign Federal
Register notices pertaining to
announcements of meetings and other
committee management activities, for
both the Centers for Disease Control and
Prevention and the Agency for Toxic
Substances and Disease Registry.
Kalwant Smagh,
Director, Strategic Business Initiatives Unit,
Office of the Chief Operating Officer, Centers
for Disease Control and Prevention.
[FR Doc. 2021–17808 Filed 8–16–21; 4:15 pm]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
Notice of Award of a Single-Source
Grant To Fund Task Force for Global
Health, Inc.
Centers for Disease Control and
Prevention (CDC), Department of Health
and Human Services (HHS).
ACTION: Notice.
AGENCY:
The Centers for Disease
Control and Prevention (CDC), located
within the Department of Health and
Human Services (HHS) announces the
award of approximately $47,000,000 in
COVID–19 funding with an expected
total funding of $100,000,000 over a
five-year period to the Task Force for
SUMMARY:
PO 00000
Frm 00084
Fmt 4703
Sfmt 4703
46257
Global Health to expand the influenza
and COVID–19 vaccine coverage in lowand middle-income countries.
DATES: The period for this award will be
September 30, 2021 through September
29, 2026.
FOR FURTHER INFORMATION CONTACT:
Archana Kumar, National Center for
Immunization and Respiratory Diseases,
Centers for Disease Control and
Prevention, 1600 Clifton Road NE, MS–
H24–8, Atlanta, GA 30329, Telephone:
800–232–6348, E-Mail: eocevent445@
cdc.gov.
SUPPLEMENTARY INFORMATION: The
single-source award will introduce and/
or expand influenza vaccine programs,
contribute to evidence base for
influenza control and prevention, and
leverage efforts to deploy pandemic
vaccines to low- and middle-income
countries.
The Task Force for Global Health will
be awarded as a single-source because of
their specific experience collaborating
with multiple partners in facilitating the
use of influenza vaccines in low- to
middle-income countries and in
developing local and global evidence
base for sustained use of lifesaving
vaccines since 2014. The Task Force for
Global Health is uniquely qualified to
support countries to plan for,
implement and evaluate COVID–19
vaccination programs since they are
currently working with the same risk
groups using established tools and
platforms under an existing cooperative
agreement. The Task Force for Global
Health leads the Partnership for
Influenza Vaccine Introduction which
includes ministries of health from 15
countries, private industry, and the
United Nations International Children’s
Emergency Fund. This Partnership
creates sustainable, seasonal influenza
vaccination programs in the targeted
countries, works with the World Health
Organization to prepare for pandemic
influenza, and supports countries’
efforts to control and prevent seasonal
outbreaks.
Summary of the Award
Recipient: The Task Force For Global
Health.
Purpose of the Award: The purpose of
award is to expand the use of influenza
and COVID–19 vaccines in low- and
middle-income countries (LMICs),
support influenza vaccine introduction
through a public-private partnership,
establish an evidence base for global
vaccine introduction decisions, and
leverage this partnership to support
readiness for and deployment of future
pandemic vaccines. The recipient will
be expected to assist partner countries
E:\FR\FM\18AUN1.SGM
18AUN1
46258
Federal Register / Vol. 86, No. 157 / Wednesday, August 18, 2021 / Notices
to plan, implement, and evaluate
vaccination programs for influenza and
COVID–19.
Amount of Award: $47,000,000 in
Federal Fiscal Year (FFY) 2021 funds,
and an estimated total of $100,000,000
over the five-year period of
performance, subject to availability of
funds.
Period of Performance: September 30,
2021 through September 29, 2026.
Authority: Section 307 of the Public
Health Service Act, as amended (42
U.S.C. 242l).
Dated: August 12, 2021.
Joseph I. Hungate III,
Deputy Director, Office of Financial
Resources, Office of the Chief Operating
Officer, Centers for Disease Control and
Prevention.
[FR Doc. 2021–17678 Filed 8–17–21; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Administration for Children and
Families
Notice of Meeting
Office on Trafficking in
Persons, Administration for Children
and Families, Department of Health and
Human Services.
ACTION: Announcement of meeting and
call for public comments on states’
efforts to improve the nation’s response
to the sex trafficking of children and
youth.
AGENCY:
Notice is hereby given,
pursuant to the provisions of the
Federal Advisory Committee Act
(FACA) and the Preventing Sex
Trafficking and Strengthening Families
Act, that a meeting of the National
Advisory Committee on the Sex
Trafficking of Children and Youth in the
United States (the Committee) will be
held on September 8 and 9, 2021. The
purpose of the meeting is for the
Committee to begin reviewing responses
to the Committee’s State SelfAssessment Survey and develop a
framework for the Committee’s final
report. The members of the Committee
request comments from the public to
inform their ongoing work and final
report. Please submit your comments to
NAC@nhttac.org with the subject ‘‘NAC
Comments’’ as soon as possible and
before September 6, 2021.
DATES: The meeting will be held on
September 8 and 9, 2021.
ADDRESSES: The meeting will be held
virtually. Please register for this event
online: https://www.acf.hhs.gov/otip/
jbell on DSKJLSW7X2PROD with NOTICES
SUMMARY:
VerDate Sep<11>2014
17:34 Aug 17, 2021
Jkt 253001
partnerships/national-advisorycommittee.
FOR FURTHER INFORMATION, CONTACT:
Katherine Chon (Designated Federal
Officer) at EndTrafficking@acf.hhs.gov
or (202) 205–5778, or 330 C Street SW,
Washington, DC 20201. Additional
information is available at https://
www.acf.hhs.gov/otip/partnerships/thenational-advisory-committee.
SUPPLEMENTARY INFORMATION: The
formation and operation on behalf of the
Committee are governed by the
provisions of Public Law 92–463, as
amended (5 U.S.C. App. 2), which sets
forth standards for the formation and
use of federal advisory committees.
Purpose of the Committee: The
purpose of the Committee is to advise
the Secretary and the Attorney General
on practical and general policies
concerning improvements to the
nation’s response to the sex trafficking
of children and youth in the United
States. HHS established the Committee
pursuant to Section 121 of the
Preventing Sex Trafficking and
Strengthening Families Act of 2014
(Pub. L. 113–183).
Tentative Agenda: The agenda can be
found at https://www.acf.hhs.gov/otip/
partnerships/the-national-advisorycommittee. To submit written
statements, email NAC@nhttac.org, by
September 6, 2021. Please include your
name, organization, and phone number.
More details on these options are below.
Public Accessibility to the Meeting:
Pursuant to 5 U.S.C. 552b and 41 CFR
102–3.140 through 102–3.165, and
subject to the availability of space, this
meeting is open to the public virtually.
Written Statements: Pursuant to 41
CFR 102–3.105(j) and 102–3.140 and
section 10(a)(3) of the Federal Advisory
Committee Act, the public may submit
written statements in response to the
stated agenda of the meeting, or to the
Committee’s mission, in general.
Organizations with recommendations
on strategies to engage states and
stakeholders are encouraged to submit
their comments or resources (hyperlinks
preferred). Written comments or
statements received after September 6,
2021, may not be provided to the
Committee until its next meeting.
Verbal Statements: Pursuant to 41
CFR 102–3.140d, the Committee is not
obligated to allow a member of the
public to speak or otherwise address the
Committee during the meeting.
Members of the public are invited to
provide verbal statements during the
Committee meeting only at the time and
manner described in the agenda. The
request to speak should include a brief
statement of the subject matter to be
PO 00000
Frm 00085
Fmt 4703
Sfmt 4703
addressed and should be relevant to the
stated agenda of the meeting or the
Committee’s mission in general.
Minutes: The minutes of this meeting
will be available for public review and
copying within 90 days at: https://
www.acf.hhs.gov/otip/partnerships/thenational-advisory-committee.
Linda Hitt,
Director, Executive Secretariat.
[FR Doc. 2021–17714 Filed 8–17–21; 8:45 am]
BILLING CODE 4184–40–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Government-Owned Inventions;
Availability for Licensing
AGENCY:
National Institutes of Health,
HHS.
ACTION:
Notice.
The invention listed below is
owned by an agency of the U.S.
Government and is available for
licensing to achieve expeditious
commercialization of results of
federally-funded research and
development. Foreign patent
applications are filed on selected
inventions to extend market coverage
for companies and may also be available
for licensing.
FOR FURTHER INFORMATION CONTACT:
Elizabeth Pitts, Ph.D., 240–669–5299;
elizabeth.pitts@nih.gov. Licensing
information may be obtained by
communicating with the indicated
licensing contact at the Technology
Transfer and Intellectual Property
Office, National Institute of Allergy and
Infectious Diseases, 5601 Fishers Lane,
Rockville, MD 20852; tel. 301–496–
2644. A signed Confidential Disclosure
Agreement will be required to receive
copies of unpublished information
related to the invention.
SUPPLEMENTARY INFORMATION:
Technology description follows.
SUMMARY:
Tumor Associated Calcium Signal
Transducer 2 (TACSTD2)Overexpressing Huh7.5 Cells That Are
More Permissive to HCV Cell Entry and
Replication Compared to the Model
Huh7.5 Cell Line
Description of Technology
Worldwide, 130–150 million
individuals are chronically infected
with hepatitis C virus (HCV), a major
cause of liver-associated morbidity and
mortality worldwide. Despite recent
advances in antiviral drugs that can cure
some individuals, a rapid decline of the
E:\FR\FM\18AUN1.SGM
18AUN1
]]>Agencies
[Federal Register Volume 86, Number 157 (Wednesday, August 18, 2021)]
[Notices]
[Pages 46257-46258]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2021-17678]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
Notice of Award of a Single-Source Grant To Fund Task Force for
Global Health, Inc.
AGENCY: Centers for Disease Control and Prevention (CDC), Department of
Health and Human Services (HHS).
ACTION: Notice.
-----------------------------------------------------------------------
SUMMARY: The Centers for Disease Control and Prevention (CDC), located
within the Department of Health and Human Services (HHS) announces the
award of approximately $47,000,000 in COVID-19 funding with an expected
total funding of $100,000,000 over a five-year period to the Task Force
for Global Health to expand the influenza and COVID-19 vaccine coverage
in low- and middle-income countries.
DATES: The period for this award will be September 30, 2021 through
September 29, 2026.
FOR FURTHER INFORMATION CONTACT: Archana Kumar, National Center for
Immunization and Respiratory Diseases, Centers for Disease Control and
Prevention, 1600 Clifton Road NE, MS-H24-8, Atlanta, GA 30329,
Telephone: 800-232-6348, E-Mail: [email protected].
SUPPLEMENTARY INFORMATION: The single-source award will introduce and/
or expand influenza vaccine programs, contribute to evidence base for
influenza control and prevention, and leverage efforts to deploy
pandemic vaccines to low- and middle-income countries.
The Task Force for Global Health will be awarded as a single-source
because of their specific experience collaborating with multiple
partners in facilitating the use of influenza vaccines in low- to
middle-income countries and in developing local and global evidence
base for sustained use of lifesaving vaccines since 2014. The Task
Force for Global Health is uniquely qualified to support countries to
plan for, implement and evaluate COVID-19 vaccination programs since
they are currently working with the same risk groups using established
tools and platforms under an existing cooperative agreement. The Task
Force for Global Health leads the Partnership for Influenza Vaccine
Introduction which includes ministries of health from 15 countries,
private industry, and the United Nations International Children's
Emergency Fund. This Partnership creates sustainable, seasonal
influenza vaccination programs in the targeted countries, works with
the World Health Organization to prepare for pandemic influenza, and
supports countries' efforts to control and prevent seasonal outbreaks.
Summary of the Award
Recipient: The Task Force For Global Health.
Purpose of the Award: The purpose of award is to expand the use of
influenza and COVID-19 vaccines in low- and middle-income countries
(LMICs), support influenza vaccine introduction through a public-
private partnership, establish an evidence base for global vaccine
introduction decisions, and leverage this partnership to support
readiness for and deployment of future pandemic vaccines. The recipient
will be expected to assist partner countries
[[Page 46258]]
to plan, implement, and evaluate vaccination programs for influenza and
COVID-19.
Amount of Award: $47,000,000 in Federal Fiscal Year (FFY) 2021
funds, and an estimated total of $100,000,000 over the five-year period
of performance, subject to availability of funds.
Period of Performance: September 30, 2021 through September 29,
2026.
Authority: Section 307 of the Public Health Service Act, as amended
(42 U.S.C. 242l).
Dated: August 12, 2021.
Joseph I. Hungate III,
Deputy Director, Office of Financial Resources, Office of the Chief
Operating Officer, Centers for Disease Control and Prevention.
[FR Doc. 2021-17678 Filed 8-17-21; 8:45 am]
BILLING CODE 4163-18-P
